UHC Conducting Research Study on Breast Cancer
University Hospital & Clinics (UHC), in conjunction with Cancer Center of Acadiana (CCA), is seeking men and women, ages 18 years and older, diagnosed with a specific type of breast cancer to participate in a clinical trial. Participation in this study is entirely voluntary.
This research study will assess the effectiveness of a new experimental type of cancer therapy versus other agents commonly chosen by physicians to treat metastatic breast cancer patients with germline BRCA 1 or BRCA2 mutations (genetic predisposition).
This is a Phase III clinical trial offering the standard care of treatment.
Medical Oncologist Windy Dean-Colomb, M.D., Director of Oncology and Oncological Research at UHC, will preside over this study.
UHC participates in clinical trials and studies to help improve patient care and disease prevention. Clinical trials can offer several benefits, such as access to newer treatments and drugs that might not otherwise be available. Trials also help expand knowledge about the best ways to treat cancer.
Clinical trials also empower a patient who may not be responding ideally to treatment to make his or her own decision. Physicians, nurses and other team members at UHC will thoroughly instruct a patient on potential risks and benefits of participating in a clinical trial. The staff will then closely monitor and assess the progress of the trial and continue this through follow-up care.
When patients participate in a clinical trial, they are not only advancing medical technology, they are providing a valuable benefit to future generations. The goal of clinical trials through Lafayette General Health is to support the patient-centered approach to health care.
For more information on this and other clinical trials available, call (337) 289-8658 or visit our clinical trials area.